ACADIA Pharmaceuticals Inc. (ACAD)
Company Info
| ISIN | US0042251084 |
|---|---|
| CUSIP | 004225108 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $3.41B |
|---|---|
| EPS | -$0.67 |
| PEG Ratio | -0.42 |
| Revenue (TTM) | $550.90M |
| Gross Profit (TTM) | $145.49M |
| EBITDA (TTM) | -$124.29M |
| Year Range | $13.73 - $33.99 |
| Target Price | $31.13 |
| Short % | 8.75% |
| Short Ratio | 8.79 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in ACADIA Pharmaceuticals Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ACAD vs. ABT
Return
ACADIA Pharmaceuticals Inc. had a return of 30.53% year-to-date (YTD) and 21.95% in the last 12 months. Over the past 10 years, ACADIA Pharmaceuticals Inc. had an annualized return of -3.21%, while the S&P 500 had an annualized return of 9.51%, indicating that ACADIA Pharmaceuticals Inc. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -25.22% | -6.34% |
| 6 months | 12.45% | 2.77% |
| Year-To-Date | 30.53% | 9.76% |
| 1 year | 21.95% | 14.57% |
| 5 years (annualized) | -0.65% | 7.80% |
| 10 years (annualized) | -3.21% | 9.51% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -9.04% | 13.34% | 10.17% | 1.91% | 22.09% | -7.59% | -22.87% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for ACADIA Pharmaceuticals Inc. (ACAD) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ACAD ACADIA Pharmaceuticals Inc. | 0.56 | ||||
^GSPC S&P 500 | 1.05 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the ACADIA Pharmaceuticals Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the ACADIA Pharmaceuticals Inc. is 96.29%, recorded on Nov 12, 2010. It took 645 trading sessions for the portfolio to recover.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -96.29% | Mar 17, 2006 | 1175 | Nov 12, 2010 | 645 | Jun 10, 2013 | 1820 |
| -77.18% | Jul 8, 2020 | 491 | Jun 21, 2022 | — | — | — |
| -73.99% | Jul 20, 2015 | 777 | Aug 17, 2018 | 327 | Dec 5, 2019 | 1104 |
| -40.8% | Feb 28, 2014 | 32 | Apr 14, 2014 | 161 | Dec 2, 2014 | 193 |
| -38.42% | Dec 9, 2019 | 67 | Mar 16, 2020 | 29 | Apr 27, 2020 | 96 |
Volatility Chart
The current ACADIA Pharmaceuticals Inc. volatility is 21.50%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.